Have a symptom?
See what questions
a doctor would ask.
News » FDA approves new osteoporosis drug

FDA approves new osteoporosis drug

The Food and Drug Administration has approved Menostar which is used to prevent osteoporosis. It is a transdermal patch that delivers very low doses of oestrogen daily. Tests show that it does not preclude endometrial or other cancers and increased spine bone mineral density by 2.6% over 2 years.

Source: summary of medical news story as reported by Berlex

Related Disease Topics:

Article Source Details

About: FDA approves new osteoporosis drug

Date: 9 June 2004

Source: Berlex


More News Topics

  • Two hospitals faced lawsuits over undiagnosed cancer leading to death
  • Two medical mistakes performed in same hospital
  • Two new drugs approved by FDA
  • Two people sue over wrongful sex-change
  • Two rare but painful conditions often misdiagnosed
  • Two sisters face different prognosis due to late diagnosis
  • Two thirds of thyroid problems undiagnosed
  • Two women develop chronic Lyme disease because doctors were unable to diagnose their condition
  • UK aging population will stretch cancer resources in the future
  • UK Autopsy Study of Misdiagnosis

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise